Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Mar-23 4:11 PM View:  | Tupper Colleen EVP & Chief Financial Officer | Collegium Pharmaceutical, Inc (COLL) | 15-Mar-23 | Private Sale (Planned) | 31,640 | $23.77 | $752,165.00 | (23%) 137.06K to 105.42K | |
| 03-Mar-23 4:08 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 01-Mar-23 | Private Sale (Planned) | 13,324 | $26.70 | $355,751.00 | (9%) 148.21K to 134.88K | |
| 14-Feb-23 5:18 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 13-Feb-23 | Sale (Planned) | 21,811 | $26.88 | $586,280.00 | (14%) 159.31K to 137.5K | |
| 14-Feb-23 5:16 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 13-Feb-23 | Planned Option Sale | 11,250 | $26.88 | $302,400.00 | (3%) 411.34K to 400.09K | |
| 14-Feb-23 5:16 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 13-Feb-23 | Option Exercise | 11,250 | $15.90 | $178,875.00 | 3% 400.09K to 411.34K | |
| 14-Feb-23 5:16 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-23 | Grant | 255,194 | -- | -- | 103% 248.75K to 503.94K | |
| 14-Feb-23 5:15 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-23 | Grant | 66,734 | -- | -- | 65% 102.8K to 169.53K | |
| 14-Feb-23 5:17 PM View: | Tupper Colleen EVP & Chief Financial Officer | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-23 | Payment of Exercise | 10,854 | $26.75 | $290,344.00 | (7%) 147.91K to 137.06K | |
| 14-Feb-23 5:18 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-23 | Grant | 73,864 | -- | -- | 67% 109.5K to 183.36K | |
| 14-Feb-23 5:16 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-23 | Payment of Exercise | 103,857 | $26.75 | $2,778,170.00 | (21%) 503.94K to 400.09K | |
| 14-Feb-23 5:15 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-23 | Payment of Exercise | 21,326 | $26.75 | $570,470.00 | (13%) 169.53K to 148.21K | |
| 14-Feb-23 5:19 PM View: | Smith Thomas B EVP and Chief Medical Officer | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-23 | Grant | 31,185 | -- | -- | 100% 0 to 31.18K | |
| 14-Feb-23 5:18 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-23 | Payment of Exercise | 24,046 | $26.75 | $643,230.00 | (13%) 183.36K to 159.31K | |
| 14-Feb-23 5:17 PM View: | Tupper Colleen EVP & Chief Financial Officer | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-23 | Grant | 57,610 | -- | -- | 64% 90.3K to 147.91K | |
| 11-Jan-23 4:06 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 09-Jan-23 | Private Sale (Planned) | 17,834 | $27.39 | $488,554.00 | (15%) 120.63K to 102.8K | |
| 27-Dec-22 7:17 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 27-Dec-22 | Option Exercise | 19,815 | $16.15 | $320,012.00 | 71% 28.02K to 47.84K | |
| 27-Dec-22 7:17 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 27-Dec-22 | Planned Option Sale | 19,815 | $23.73 | $470,253.00 | (41%) 47.84K to 28.02K | |
| 27-Dec-22 7:16 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 27-Dec-22 | Sale (Planned) | 2,204 | $23.75 | $52,340.60 | (< 1%) 250.95K to 248.75K | |
| 27-Dec-22 7:17 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 23-Dec-22 | Option Exercise | 4,989 | $16.15 | $80,572.40 | 18% 28.02K to 33.01K | |
| 27-Dec-22 7:17 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 23-Dec-22 | Planned Option Sale | 4,989 | $23.00 | $114,747.00 | (15%) 33.01K to 28.02K | |
| 27-Dec-22 7:16 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 23-Dec-22 | Sale (Planned) | 147 | $23.00 | $3,381.00 | (< 1%) 251.1K to 250.95K | |
| 27-Dec-22 7:17 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 22-Dec-22 | Option Exercise | 237 | $16.15 | $3,827.55 | < 1% 28.02K to 28.26K | |
| 27-Dec-22 7:17 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 22-Dec-22 | Planned Option Sale | 237 | $23.00 | $5,451.00 | (< 1%) 28.26K to 28.02K | |
| 27-Dec-22 7:16 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 22-Dec-22 | Private Sale (Planned) | 110 | $23.00 | $2,530.00 | (< 1%) 251.21K to 251.1K | |
| 21-Dec-22 7:28 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 21-Dec-22 | Planned Option Sale | 46,600 | $23.11 | $1,076,930.00 | (62%) 74.62K to 28.02K | |
| 21-Dec-22 7:28 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 21-Dec-22 | Sale (Planned) | 7,333 | $23.11 | $169,466.00 | (3%) 258.54K to 251.21K | |
| 21-Dec-22 7:28 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 21-Dec-22 | Option Exercise | 46,600 | $16.15 | $752,590.00 | 166% 28.02K to 74.62K | |
| 21-Dec-22 7:28 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 20-Dec-22 | Planned Option Sale | 33,758 | $23.08 | $779,135.00 | (55%) 61.78K to 28.02K | |
| 21-Dec-22 7:28 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 20-Dec-22 | Sale (Planned) | 9,375 | $23.07 | $216,281.00 | (3%) 267.92K to 258.54K | |
| 21-Dec-22 7:28 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 20-Dec-22 | Option Exercise | 33,758 | $16.15 | $545,192.00 | 120% 28.02K to 61.78K | |
| 21-Dec-22 7:28 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 19-Dec-22 | Planned Option Sale | 3,606 | $23.04 | $83,082.20 | (11%) 31.63K to 28.02K | |
| 21-Dec-22 7:28 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 19-Dec-22 | Private Sale (Planned) | 1,134 | $23.01 | $26,093.30 | (< 1%) 269.05K to 267.92K | |
| 21-Dec-22 7:28 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 19-Dec-22 | Option Exercise | 3,606 | $16.15 | $58,236.90 | 13% 28.02K to 31.63K | |
| 14-Dec-22 6:06 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 13-Dec-22 | Planned Option Sale | 161,687 | $22.16 | $3,582,980.00 | (85%) 189.71K to 28.02K | |
| 14-Dec-22 6:06 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 13-Dec-22 | Option Exercise | 161,687 | $15.10 | $2,441,400.00 | 577% 28.02K to 189.71K | |
| 14-Dec-22 6:06 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 12-Dec-22 | Planned Option Sale | 27,920 | $22.01 | $614,519.00 | (50%) 55.94K to 28.02K | |
| 14-Dec-22 6:06 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 12-Dec-22 | Option Exercise | 27,920 | $15.09 | $421,334.00 | 100% 28.02K to 55.94K | |
| 05-Dec-22 6:16 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 02-Dec-22 | Sale (Planned) | 54,400 | $23.07 | $1,255,010.00 | (17%) 323.45K to 269.05K | |
| 05-Dec-22 6:16 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 01-Dec-22 | Option Exercise | 76,653 | $15.90 | $1,218,780.00 | 24% 323.45K to 400.11K | |
| 05-Dec-22 6:16 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 01-Dec-22 | Planned Option Sale | 76,653 | $22.47 | $1,722,390.00 | (19%) 400.11K to 323.45K | |
| 30-Nov-22 5:59 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 28-Nov-22 | Planned Option Sale | 43 | $22.00 | $946.00 | (< 1%) 323.5K to 323.45K | |
| 30-Nov-22 5:59 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 28-Nov-22 | Option Exercise | 43 | $15.90 | $683.70 | < 1% 323.45K to 323.5K | |
| 25-Nov-22 6:11 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 22-Nov-22 | Option Exercise | 65 | $15.90 | $1,033.50 | < 1% 323.45K to 323.52K | |
| 25-Nov-22 6:11 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 22-Nov-22 | Planned Option Sale | 65 | $22.00 | $1,430.00 | (< 1%) 323.52K to 323.45K | |
| 22-Nov-22 4:44 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 18-Nov-22 | Option Exercise | 1,989 | $15.90 | $31,625.10 | < 1% 323.45K to 325.44K | |
| 22-Nov-22 4:44 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 18-Nov-22 | Planned Option Sale | 1,989 | $22.02 | $43,797.80 | (< 1%) 325.44K to 323.45K | |
| 06-Oct-22 4:23 PM View: | Tupper Colleen EVP & Chief Financial Officer | Collegium Pharmaceutical, Inc (COLL) | 04-Oct-22 | Market Sale (Planned) | 4,350 | $17.35 | $75,472.50 | (5%) 94.65K to 90.3K | (10%) |
| 16-Sep-22 4:22 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 15-Sep-22 | Market Sale (Planned) | 38,589 | $18.07 | $697,303.00 | (26%) 148.08K to 109.5K | (5%) |
| 15-Aug-22 4:34 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 11-Aug-22 | Market Sale (Planned) | 300 | $20.01 | $6,003.00 | (< 1%) 148.38K to 148.08K | 5% |
| 13-Jul-22 4:50 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 11-Jul-22 | Payment of Exercise | 594 | $17.48 | $10,383.10 | (< 1%) 121.23K to 120.63K | (9%) |
